Subscribe To
Deciphera pharmaceuticals: clawing its way back
Deciphera Pharmaceuticals is focused on the development of their multikinase inhibitor ripretinib for the treatment of gastrointestinal stromal tumor....
August 22, 2023, 5:06 am
Aerovate therapeutics presents nonclinical pharmacokinetic data in support of av-101, a novel dry powder inhaled formulation of imatinib, at the american thoracic society (ats) 2023 international conf
Direct delivery of imatinib to the lungs in nonclinical species demonstrated increased lung exposure co...
May 22, 2023, 5:15 pm
Aerami therapeutics to present pharmacokinetic data supporting aer-901 (inhaled imatinib) for pulmonary hypertension at the 2023 american thoracic society (ats) international conference
DURHAM, N.C., May 11, 2023 (GLOBE NEWSWIRE) — Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing ...
May 11, 2023, 12:00 pm
Aerovate: developing an exciting pah drug, initiating with a buy
Aerovate is a SMID-cap biotech developing an inhaled imatinib for pulmonary arterial hypertension. AV-1...
January 29, 2023, 7:12 am